These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11313284)

  • 21. Expansion of the Knops blood group system and subdivision of Sl(a).
    Moulds JM; Zimmerman PA; Doumbo OK; Diallo DA; Atkinson JP; Krych-Goldberg M; Hourcade DE; Moulds JJ
    Transfusion; 2002 Feb; 42(2):251-6. PubMed ID: 11896343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity.
    Sinha S; Jha GN; Anand P; Qidwai T; Pati SS; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Venkatesh V; Habib S
    Hum Immunol; 2009 Apr; 70(4):244-50. PubMed ID: 19480840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus.
    Oliveira LC; Kretzschmar GC; Dos Santos ACM; Camargo CM; Nisihara RM; Farias TDJ; Franke A; Wittig M; Schmidt E; Busch H; Petzl-Erler ML; Boldt ABW
    Front Immunol; 2019; 10():2585. PubMed ID: 31824479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe.
    Grueger D; Zeretzke A; Habicht CP; Skaik Y; Wagner FF; Scharberg EA; Costelloe A; Martens J; Verboom M; Bugert P; Schneeweiss C
    Transfusion; 2020 Oct; 60(10):2408-2418. PubMed ID: 32870515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.
    Cockburn IA; Mackinnon MJ; O'Donnell A; Allen SJ; Moulds JM; Baisor M; Bockarie M; Reeder JC; Rowe JA
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):272-7. PubMed ID: 14694201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
    Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
    Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility.
    Rowe JA; Raza A; Diallo DA; Baby M; Poudiougo B; Coulibaly D; Cockburn IA; Middleton J; Lyke KE; Plowe CV; Doumbo OK; Moulds JM
    Genes Immun; 2002 Dec; 3(8):497-500. PubMed ID: 12486610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased deposition of C3b on red cells with low CR1 and CD55 in a malaria-endemic region of western Kenya: implications for the development of severe anemia.
    Odhiambo CO; Otieno W; Adhiambo C; Odera MM; Stoute JA
    BMC Med; 2008 Aug; 6():23. PubMed ID: 18717995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The polymorphism of Knops blood group system in Korean population and their relationship with HLA system.
    Yoon JH; Oh S; Shin S; Park JS; Roh EY; Song EY; Park MH; Han KS; Chang JY
    Hum Immunol; 2013 Feb; 74(2):196-8. PubMed ID: 23127551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the Knops blood group and its role in malaria.
    Moulds JM
    Vox Sang; 2002 Aug; 83 Suppl 1():185-8. PubMed ID: 12617133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Knops blood-group system: a review.
    Moulds JM
    Immunohematology; 2010; 26(1):2-7. PubMed ID: 20795311
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya.
    Thathy V; Moulds JM; Guyah B; Otieno W; Stoute JA
    Malar J; 2005 Nov; 4():54. PubMed ID: 16277654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study.
    Tettey R; Ayeh-Kumi P; Tettey P; Adjei GO; Asmah RH; Dodoo D
    Pathog Glob Health; 2015 Jul; 109(5):247-52. PubMed ID: 25916414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knops blood group haplotypes among distinct Brazilian populations.
    Covas DT; de Oliveira FS; Rodrigues ES; Abe-Sandes K; Silva WA; Fontes AM
    Transfusion; 2007 Jan; 47(1):147-53. PubMed ID: 17207243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Knops blood group polymorphisms and susceptibility to malaria in an endemic area of the Brazilian Amazon.
    Fontes AM; Kashima S; Bonfim-Silva R; Azevedo R; Abraham KJ; Albuquerque SR; Bordin JO; Júnior DM; Covas DT
    Genet Mol Biol; 2011 Oct; 34(4):539-45. PubMed ID: 22215954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement receptor 1 variants confer protection from severe malaria in Odisha, India.
    Panda AK; Panda M; Tripathy R; Pattanaik SS; Ravindran B; Das BK
    PLoS One; 2012; 7(11):e49420. PubMed ID: 23152904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.
    Cockburn IA; Rowe JA
    Int J Immunogenet; 2006 Feb; 33(1):17-20. PubMed ID: 16426237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralization of Knops system antibodies using soluble complement receptor 1.
    Moulds JM; Rowe KE
    Transfusion; 1996 Jun; 36(6):517-20. PubMed ID: 8669083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for malaria selection of a CR1 haplotype in Sardinia.
    Kosoy R; Ransom M; Chen H; Marconi M; Macciardi F; Glorioso N; Gregersen PK; Cusi D; Seldin MF
    Genes Immun; 2011 Oct; 12(7):582-8. PubMed ID: 21593778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.